News

The head of the Food and Drug Administration has repeatedly claimed in recent interviews that no scientists have been laid ...
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.
Dr. Stephen C. Weber, MD, FACS Head of ADHC's Medical Advisory Board To Lead Next Stage Of GlucoGuard Development Del Mar, ...
The FDA is currently reviewing Merck’s sBLA for Keytruda in head and neck cancer, with a target action date of June 23.
The Upper East Regional Office of the Food and Drugs Authority (FDA) has cautioned sachet water producers against production ...
As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene ...
Spruce Biosciences has swept away 55% of its employees. The biotech took the action days after inking a deal for a former ...
Following a positive readout for its closely watched PD-1xVEGF bispecific ivonescimab, Akeso has won the FDA’s go-ahead for ...
CR specifically examined the number of foodborne illnesses and deaths in 2024, the spread of the outbreaks and food recalls.
The former head of Johnson & Johnson’s worldwide medtech business, Ashley McEvoy, has signed up to lead the insulin ...
In advanced head and neck squamous cell carcinoma, evorpacept and Keytruda didn’t meet the primary endpoints of the ASPEN-03 ...